Skip to content

Antibody trials sponsored by Regeneron and Eli Lilly are off to a slow start because of a dearth of tests, overwhelmed hospitals and reluctant patients.

Coronavirus Antibody: Clinical Trials of Drugs Are Taking Longer Than Expected – The New York Times

The COVID-19 pandemic continues unabated and not impressed by the Kusher-Trump-Barr triumvirate.

Share this:

  • Share
  • Email

Like this:

Like Loading...
nelsongon, Powered by WordPress.com.
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
%d bloggers like this: